Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Sun Min | - |
dc.contributor.author | Hong, Min Hee | - |
dc.contributor.author | Ha, Sang-Jun | - |
dc.contributor.author | Hwang, Daehee | - |
dc.contributor.author | Chae, Sehyun | - |
dc.contributor.author | Koh, Yoon Woo | - |
dc.contributor.author | Choi, Eun Chang | - |
dc.contributor.author | Kim, Se-Heon | - |
dc.contributor.author | Kim, Da-Hee | - |
dc.contributor.author | Yoon, Sun Och | - |
dc.contributor.author | Kim, Hye Ryun | - |
dc.date.accessioned | 2023-08-16T09:31:15Z | - |
dc.date.available | 2023-08-16T09:31:15Z | - |
dc.date.created | 2022-01-11 | - |
dc.date.issued | 2021-09 | - |
dc.identifier.issn | 0171-5216 | - |
dc.identifier.uri | http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/300 | - |
dc.description.abstract | Purpose We aimed to investigate the prognostic value of multiple immune cell markers including programmed death-ligand 1 (PD-L1) and poliovirus receptor (PVR) in head and neck squamous cell carcinoma (HNSCC) using archival tumor tissues Methods Patients diagnosed with HNSCC who have undergone surgical resection in 2005-2012 were included. Correlations between PVR and PD-L1 expression and patient characteristics were analyzed by analysis of variance. The Kaplan-Meier method and log-rank test were used to estimate survival. P values < 0.05 were considered statistically significant. Results In total, 375 primary tumor tissues were analyzed using immunohistochemistry. High PVR expression was associated with a poor prognosis in terms of overall survival (OS) and recurrence-free survival (RFS), and tumors with high PVR expression were associated with a short OS. PD-L1 tumor expression did not have a prognostic impact on survival. Univariate analysis revealed that OS and RFS were affected by age and p16 and PVR expression; multivariate analysis revealed that age and p16 and PVR expression were the most important determinants of RFS. Conclusion PVR overexpression is a poor prognostic factor in patients with HNSCC and co-targeting PVR and PD-L1 may be a promising therapeutic option that needs further investigation. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.title | Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chae, Sehyun | - |
dc.identifier.doi | 10.1007/s00432-021-03531-8 | - |
dc.identifier.scopusid | 2-s2.0-85101215940 | - |
dc.identifier.wosid | 000620420100001 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, v.147, no.9, pp.2741 - 2750 | - |
dc.relation.isPartOf | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - |
dc.citation.title | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - |
dc.citation.volume | 147 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 2741 | - |
dc.citation.endPage | 2750 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordAuthor | Squamous cell carcinoma of head and neck | - |
dc.subject.keywordAuthor | Biomarkers | - |
dc.subject.keywordAuthor | Programmed death-ligand | - |
dc.subject.keywordAuthor | Poliovirus receptor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
61, Cheomdan-ro, Dong-gu, Daegu, Republic of Korea , 41062 053-980-8114
COPYRIGHT Korea Brain Research Institute. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.